Shares of RamediTech, which produces beauty devices and blood collection devices using ultra-small high-power laser technology, are on the rise. A corporate report from the securities industry forecasted, "Based on proprietary technology, RamediTech's platform business will see significant growth this year."
As of 11:07 AM on the 30th, RamediTech was trading at 13,800 KRW, up 1,320 KRW (10.58%) from the previous trading day.
On the same day, Oh Hyunjin, a researcher at Kiwoom Securities, stated, "The differentiating factor is the ability to target various markets such as home beauty devices through a size that is over 90% smaller than existing laser products and a reasonable price," adding, "In addition to beauty devices, there is potential for bio-industry spending through original design manufacturing (ODM) business with cosmetics companies and drug delivery."
Researcher Oh added, "According to RamediTech's securities registration statement, the performance forecast for this year is sales of 9.2 billion KRW and operating profit of 1.1 billion KRW (turning to black)," emphasizing, "It is time to focus on product competitiveness through high entry barriers and the potential for diverse business expansion."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![[Featured Stock] "Expecting Full-Scale Growth"... LaMeditech Up 10.58%](https://cphoto.asiae.co.kr/listimglink/1/2024072208164559128_1721603806.jpg)

